Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Baxter
Colorcon
Dow
Johnson and Johnson

Last Updated: November 28, 2021

DrugPatentWatch Database Preview

Patent: 9,771,358

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,771,358
Title:Dihydropyrimidine compounds and their application in pharmaceuticals
Abstract: Provided herein are dihydropyrimidine compounds and their pharmaceutical applications, especially for use in treating and preventing HBV diseases. Specifically, provided herein are compounds having Formula (I) or (Ia), or an enantiomer, a diastereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof, wherein the variables of the formulas are as defined in the specification. Also provided herein is the use of the compounds having Formula (I) or (Ia), or an enantiomer, a diastereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof for treating and preventing HBV diseases. ##STR00001##
Inventor(s): Zhang; Yingjun (Dongguan, CN), Ren; Qingyun (Dongguan, CN), Liu; Xinchang (Dongguan, CN), Goldmann; Siegfried (Dongguan, CN)
Assignee: SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN)
Application Number:15/116,226
Patent Claims:see list of patent claims

Details for Patent 9,771,358

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Hoffmann-la Roche Inc. ROFERON-A interferon alfa-2a For Injection 103145 1986-06-04 ⤷  Free Forever Trial 2034-03-28
Biogen Inc. AVONEX interferon beta-1a For Injection 103628 1996-05-17 ⤷  Free Forever Trial 2034-03-28
Biogen Inc. AVONEX interferon beta-1a Injection 103628 2003-05-28 ⤷  Free Forever Trial 2034-03-28
Biogen Inc. AVONEX interferon beta-1a Injection 103628 2012-02-27 ⤷  Free Forever Trial 2034-03-28
Emd Serono, Inc. REBIF interferon beta-1a Injection 103780 2002-03-07 ⤷  Free Forever Trial 2034-03-28
Emd Serono, Inc. REBIF interferon beta-1a Injection 103780 2004-12-17 ⤷  Free Forever Trial 2034-03-28
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Medtronic
Harvard Business School
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.